Skip to content

Pelvic Floor Muscle Evaluation in Women With Stress Urinary and Urgency Urinary Incontinence

Pelvic Floor Muscle Evaluation in Women With Stress Urinary and Urgency Urinary Incontinence. A Prospective Trial

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01391780
Enrollment
51
Registered
2011-07-12
Start date
1997-03-31
Completion date
1998-12-31
Last updated
2013-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urge Incontinence, Urinary Incontinence, Stress

Keywords

pelvic floor evaluation,, women,, stress urinary incontinence;, urgency urinary incontinence.

Brief summary

Aims: To assess pelvic floor muscle (PFM) strength in women with stress urinary incontinence (SUI) and urgency urinary incontinence (UUI). Methods: 51 women were prospectively divided into two groups, according to the symptoms as SUI (G1 = 22) or UUI (G2 = 29). Demographic data, such as number of Pads/ 24 hours, number of micturitions/ 24 hours and nocturia, delay time of urgent void (i.e., the time period for which an urgent void could be voluntarily postponed), number of parity and vaginal deliveries were obtained using a clinical questionnaire. Objective urine loss was evaluated by 60-min Pad Test. Subjective \[urine stream interruption test (UST), visual survey of perineal contraction and transvaginal digital palpation\] and objective (vaginal manometry) evaluations of PFM were performed in all patients.

Interventions

None listed

Sponsors

UPECLIN HC FM Botucatu Unesp
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* presence of stress urinary or urgency incontinence

Exclusion criteria

* neurological diseases * previous pelvic surgeries * diabetes * cognitive difficulties * vaginal and urinary infection

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026